ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024
Targeting Dual Immune Checkpoints PD-L1 and HLA-G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer.
Yu-Chuan Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papertrialcites it